Inflammatory Bowel Disease News

 
 
  • CCC 2020Lymphoma Risk Low After TNF Inhibitor Treatments Tumor necrosis factor (TNF) inhibitors are among the most effective treatments for inflammatory bowel disease, but questions about cancer risk have kept some clinicians from prescribing them.
  • CCC 2020IBD Diagnoses Rising in Children Advances in anti-TNF drugs will be in the spotlight at the upcoming Crohn's and Colitis Congress. One expert believes a cure will come in the lifetime of some of the children he currently treats.
  • Disease Activity, Treatment De-Escalation Tied to Postpartum IBD Flare Risk Women with inflammatory bowel disease (IBD) have a one-in-three chance of experiencing a disease flare during the postpartum year, new findings show.
  • EU Clears AbbVie Takeover of Allergan Subject to Conditions The European Commission said on Friday it had approved U.S. drugmaker AbbVie's planned $63 billion acquisition of Botox-maker Allergan, subject to conditions.
  • Ultrasound Effective in Monitoring Ulcerative Colitis Intestinal ultrasound (IUS) is an effective non-invasive tool for monitoring disease - and possibly treatment response - in patients with ulcerative colitis (UC), according to German researchers.
  • New Analysis Expands on Link Between Pharma Payments, Prescribing Pharmaceutical companies have paid doctors billions of dollars for consulting, promotional talks, meals and more. A new finds that doctors who received payments prescribed more of those drugs.
  • AIBD 2019IBD Biomarker Unknowns Complicate Treatment With no way to predict which patient with inflammatory bowel disease will respond to which drug, clinicians often have to use trial and error as a strategy.
  • AIBD 2019Patients With IBD Prone to Irritable Bowel Syndrome Patients in remission from inflammatory bowel disease are susceptible to irritable bowel syndrome, but diet, cognitive therapy, and medication can help treat the symptoms.
  • FDA Panel Thumbs Up for Teprotumumab for Thyroid Eye Disease FDA panel unanimously recommends approval of teprotumumab for the treatment of active thyroid eye disease. 'I think we're finally going to be able to get a lot of people some help,' said one member.
  • AIBD 2019Biosimilar for Crohn's Noninferior to Adalimumab A patent dispute means that the marketing of a biosimilar for patients with inflammatory bowel disease will be delayed, despite approval by the US Food and Drug Administration, investigators report.
  • Long-duration Vancomycin Linked to Lower Rates of C. Diff Recurrence in IBD In patients with inflammatory bowel disease (IBD), a long course of oral vancomycin is associated with lower odds of Clostridioides difficile infection recurrence than a short course, a retrospective chart review reveals.
  • AIBD 2019Emerging Treatment Options for Crohn's Drug therapies and the postoperative management of patients will be in the spotlight at the upcoming Advances in Inflammatory Bowel Diseases conference.
  • New Algorithms Guide Management of Back Pain, Arthropathy in IBD
  • Live Zoster Vaccine Safe in People on TNF Inhibitors Patients with rheumatic diseases who are on tumor-necrosis-factor inhibitor (TNFi) therapy can safely receive the live varicella zoster vaccine, without risking vaccine-related infection, a new study suggests.
  • Poor Adherence to Immunization, Screening Guidelines for Pediatric IBD Contrary to current guidelines, children with inflammatory bowel disease (IBD) often don't receive required vaccines and are not properly screened before initiation of biologics, a multicenter study from Europe reveals.
  • Otezla May Give Oral Ulcer Relief in Patients With Recurrent Aphthous Stomatitis A drug approved by the U.S. Food and Drug Administration in July to treat oral ulcers in patients with Behcet's syndrome may be a candidate for helping people with treatment-refractory recurrent aphthous stomatitis, according to correspondence from Swiss doctors published Wednesday online in The New England Journal of Medicine.
  • Crohn's Disease May Not Be a Contraindication to Hemorrhoidectomy Excisional hemorrhoidectomy may be a viable treatment option in patients with Crohn's disease who have failed nonoperative hemorrhoidal therapy, according to a retrospective study.
  • Common Drugs Affect Composition, Function of the Gut Microbiome Proton-pump inhibitors, metformin and several other commonly used drugs markedly alter the taxonomic structure and metabolic function as well as antibiotic-resistance genes in the gut microbiome, according to a study from the Netherlands.
  • Crohn's May Not Affect Survival of Patients With Small-Bowel Adenocarcinoma Although Crohn's disease is a risk factor for developing small-bowel adenocarcinoma, survival with the malignancy is similar for patients with and without Crohn's, according to a database study.
  • Inflammatory Bowel Disease More Common in the UK That Thought The number of people with inflammatory bowel diseases (IBD) in the U.K. is much higher than thought and is likely to rise over the next 10 years, according to research presented October 21 at United European Gastroenterology (UEG) Week Barcelona.